NASDAQ: MGX
Metagenomi Inc Stock Ownership - Who owns Metagenomi?

Insider buying vs selling

Have Metagenomi Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Pamela WapnickChief Financial Officer2025-03-051,808$1.88
$3.39kSell
Matthew WeinOfficer2025-03-05930$1.88
$1.74kSell
Pamela WapnickChief Financial Officer2024-12-051,559$1.86
$2.90kSell
Pamela WapnickChief Financial Officer2024-09-056,265$2.88
$18.04kSell

1 of 1

MGX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when MGX insiders and whales buy or sell their stock.

MGX Shareholders

What type of owners hold Metagenomi Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Bayer Healthcare LLC10.84%4,050,997$6.16MInsider
Sebastian Bernales8.21%3,068,786$4.66MInsider
Brian C. Thomas6.76%2,528,276$3.84MInsider
Holdings A. Novo4.65%1,739,175$2.64MInsider
Blackrock Inc3.87%1,444,948$2.20MInstitution
Vanguard Group Inc3.39%1,268,389$1.93MInstitution
Pfm Health Sciences LP2.37%885,803$1.35MInstitution
Hhlr Advisors Ltd2.08%777,768$1.18MInstitution
Morgan Stanley2.08%775,786$1.18MInstitution
Geode Capital Management LLC1.57%587,421$892.88kInstitution

1 of 3

MGX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
MGX28.70%33.25%Net SellingNet Selling
ADAP6.37%93.63%Net Selling
RANI6.64%38.47%Net Selling
VTVT0.90%99.10%Net Buying
ANRO77.00%23.00%Net Buying

Metagenomi Stock Ownership FAQ

Who owns Metagenomi?

Metagenomi (NASDAQ: MGX) is owned by 28.70% institutional shareholders, 33.25% Metagenomi insiders, and 38.06% retail investors. Bayer Healthcare LLC is the largest individual Metagenomi shareholder, owning 4.05M shares representing 10.84% of the company. Bayer Healthcare LLC's Metagenomi shares are currently valued at $6.77M.

If you're new to stock investing, here's how to buy Metagenomi stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.